Literature DB >> 12082164

Improving a circularly permuted TEM-1 beta-lactamase by directed evolution.

Joel Osuna1, Alejandra Pérez-Blancas, Xavier Soberón.   

Abstract

Circular permutation of proteins is a powerful technique to explore the importance of the polypeptide secondary structure order for attaining the final three-dimensional structure. Here, we designed a circular permutation of the TEM beta-lactamase in order to produce a new domain-forming amino acid arrangement in the polypeptide sequence. Closing the normal N- and C-termini with the connecting peptide GGS and creating new N- and C-termini at position 216, produces a severely impaired permuted protein. Introduction of a connector with random components allows the isolation of enzymes with better activities and indicates a selection for a potential helix-stop signal at the new super-secondary motif. We applied several directed-evolution cycles, starting from permuted enzymes with each of the two different connecting peptides, and selecting for antibiotic resistance and isolated several mutants with resistance levels close to those of the wild-type enzyme. We also analyze some of the data collected on the outcomes and paths of these evolutionary experiments. A purified sixth cycle variant with connector peptide GGS showed catalytic efficiency values approximately 8% of the natural enzyme.

Mesh:

Substances:

Year:  2002        PMID: 12082164     DOI: 10.1093/protein/15.6.463

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  11 in total

1.  Production of a fully functional, permuted single-chain penicillin G acylase.

Authors:  Gabriela Flores; Xavier Soberón; Joel Osuna
Journal:  Protein Sci       Date:  2004-05-07       Impact factor: 6.725

Review 2.  Laboratory-directed protein evolution.

Authors:  Ling Yuan; Itzhak Kurek; James English; Robert Keenan
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

3.  Improvement of an unusual twin-arginine transporter leader peptide by a codon-based randomization approach.

Authors:  Olga Monroy-Lagos; Xavier Soberon; Paul Gaytan; Joel Osuna
Journal:  Appl Environ Microbiol       Date:  2006-05       Impact factor: 4.792

4.  Multiple global suppressors of protein stability defects facilitate the evolution of extended-spectrum TEM β-lactamases.

Authors:  Nicholas G Brown; Jeanine M Pennington; Wanzhi Huang; Tulin Ayvaz; Timothy Palzkill
Journal:  J Mol Biol       Date:  2010-10-16       Impact factor: 5.469

5.  Directed evolution of protein switches and their application to the creation of ligand-binding proteins.

Authors:  Gurkan Guntas; Thomas J Mansell; Jin Ryoun Kim; Marc Ostermeier
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-01       Impact factor: 11.205

6.  Genetic and structural characterization of an L201P global suppressor substitution in TEM-1 beta-lactamase.

Authors:  David C Marciano; Jeanine M Pennington; Xiaohu Wang; Jian Wang; Yu Chen; Veena L Thomas; Brian K Shoichet; Timothy Palzkill
Journal:  J Mol Biol       Date:  2008-09-16       Impact factor: 5.469

7.  Network models of TEM β-lactamase mutations coevolving under antibiotic selection show modular structure and anticipate evolutionary trajectories.

Authors:  Violeta Beleva Guthrie; Jennifer Allen; Manel Camps; Rachel Karchin
Journal:  PLoS Comput Biol       Date:  2011-09-22       Impact factor: 4.475

8.  Circular permutation in the Ω-loop of TEM-1 β-lactamase results in improved activity and altered substrate specificity.

Authors:  Gurkan Guntas; Manu Kanwar; Marc Ostermeier
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

9.  Crystal structure of circular permuted RoCBM21 (CP90): dimerisation and proximity of binding sites.

Authors:  Preyesh Stephen; Kuo-Chang Cheng; Ping-Chiang Lyu
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

10.  Variations within class-A β-lactamase physiochemical properties reflect evolutionary and environmental patterns, but not antibiotic specificity.

Authors:  Deeptak Verma; Donald J Jacobs; Dennis R Livesay
Journal:  PLoS Comput Biol       Date:  2013-07-18       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.